Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An mTOR and DNA-PK dual inhibitor CC-115 hinders non-small cell lung cancer cell growth
Fagui Chen, Huasi Zhao, Chenhui Li, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 9

Showing 9 citing articles:

From carcinogenesis to therapeutic avenues: lncRNAs and mTOR crosstalk in lung cancer
Md Sadique Hussain, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155015-155015
Closed Access | Times Cited: 25
Pseudolaric acid B suppresses NSCLC progression through the ROS/AMPK/mTOR/autophagy signalling pathway
Dan Luo, Fang He, Jingyun Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116614-116614
Open Access | Times Cited: 6
Secrets of DNA-PKcs beyond DNA repair
Sydney Camfield, Sayan Chakraborty, Shailendra Kumar Dhar Dwivedi, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5
Targeting the DNA Damage Response Machinery for Lung Cancer Treatment
Katharigatta N. Venugopala
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1475-1475
Open Access | Times Cited: 17
Medicinal chemistry breakthroughs on ATM, ATR, and DNA-PK inhibitors as prospective cancer therapeutics
Ram Lal Sharma, Anshul Mishra, Monika Bhardwaj, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts
Julian Scheper, Laura S. Hildebrand, Eva-Maria Faulhaber, et al.
Strahlentherapie und Onkologie (2022) Vol. 199, Iss. 12, pp. 1128-1139
Open Access | Times Cited: 14
Implication of mTOR Signaling in NSCLC: Mechanisms and Therapeutic Perspectives
Antonios N. Gargalionis, Kostas A. Papavassiliou, Athanasios G. Papavassiliou
Cells (2023) Vol. 12, Iss. 15, pp. 2014-2014
Open Access | Times Cited: 7
Deep Learning Unlocks Label-Free Viability Assessment of Cancer Spheroids in Microfluidics
Chun‐Cheng Chiang, Rajiv Anne, Pooja A. Chawla, et al.
Lab on a Chip (2024) Vol. 24, Iss. 12, pp. 3169-3182
Open Access | Times Cited: 2
Potential Anticancer Activity of Novel Triazoles and Related Derivatives
José Aguirre-de Paz, Nancy Lara‐Almazán, Alejandra Ancira-Cortez, et al.
Interdisciplinary cancer research (2024)
Closed Access
Page 1

Scroll to top